Rare diseases
Investigational molecules
Locations
Back to Italy10 clinical trials in Gussago, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A study to evaluate the effectiveness and safety of usnoflast in adults with Amyotrophic Lateral Sclerosis (ALS)
ItalyA study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1
ItalyA study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy
ItalyA study testing sonlicromanol in adults with genetically confirmed mitochondrial DNA 3243A>G variant causing mitochondrial disease
ItalyA Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse
ItalyStudy of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo
ItalyStudy on the Effects of Acetylcarnitine Hydrochloride in Patients with Amyotrophic Lateral Sclerosis (ALS)
ItalyStudy comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy
ItalyStudy of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression
ItalyStudy of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on amyotrophic lateral sclerosis (ALS), investigating the effects of acetyl-L-carnitine on functional disability progression. The trials aim to evaluate different dosage regimens to optimize treatment outcomes for patients.
These studies represent significant advancement in understanding ALS treatment options.
Groundbreaking research evaluating Spinal Muscular Atrophy (SMA) treatments, specifically testing Taldefgropeb Alfa in combination with existing therapies. The studies focus on measuring motor function improvements in patients.
This research aims to enhance therapeutic outcomes for SMA patients through innovative treatment combinations.
Clinical trials investigating new treatments for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), focusing on nipocalimab's efficacy in preventing disease relapse in responsive patients.
These studies represent crucial advances in managing chronic neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
